Life Science Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Life Science Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Genetics and Genomics
Cellectis technology to be assessed for use in trait development
March 31st, 2003
Pioneer Hi-Bred International, Inc., will expand its opportunity to introduce traits into maize through a new agreement with Cellectis, S.A. Under a licensing agreement, researchers at Cellectis, S.A., a subsidiary of DuPont headquartered in Des Moines, Iowa, will assess a patented Meganuclease Recombination System (MRS) from Cellectis for use in trait development. MRS is a Cellectis technology based on the use of the Meganuclease I-Sce I, a highly specific restriction endonuclease. Pioneer researchers will use this technology to stimulate homologous recombination, which could lead to faster, more efficient processes for incorporating new traits...
Source: Life Science Weekly (2003-03-31)
|
